Annual Non Current Assets
$37.78 M
+$28.64 M+313.38%
December 31, 2023
Summary
- As of February 7, 2025, LYRA annual long term assets is $37.78 million, with the most recent change of +$28.64 million (+313.38%) on December 31, 2023.
- During the last 3 years, LYRA annual non current assets has risen by +$32.87 million (+668.96%).
- LYRA annual non current assets is now at all-time high.
Performance
LYRA Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$24.31 M
-$835.00 K-3.32%
September 30, 2024
Summary
- As of February 7, 2025, LYRA quarterly long term assets is $24.31 million, with the most recent change of -$835.00 thousand (-3.32%) on September 30, 2024.
- Over the past year, LYRA quarterly non current assets has increased by +$8.66 million (+55.30%).
- LYRA quarterly non current assets is now -53.32% below its all-time high of $52.08 million, reached on March 31, 2024.
Performance
LYRA Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
LYRA Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +313.4% | +55.3% |
| 3 y3 years | +669.0% | +55.3% |
| 5 y5 years | +8645.1% | +55.3% |
LYRA Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +443.7% | -53.3% | +258.1% |
| 5 y | 5-year | at high | +679.9% | -53.3% | +612.3% |
| alltime | all time | at high | +8645.1% | -53.3% | +612.3% |
Lyra Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $24.31 M(-3.3%) |
| Jun 2024 | - | $25.15 M(-51.7%) |
| Mar 2024 | - | $52.08 M(+37.9%) |
| Dec 2023 | $104.82 M(+4.0%) | $37.78 M(+141.3%) |
| Sep 2023 | - | $15.65 M(+110.9%) |
| Jun 2023 | - | $7.42 M(-18.2%) |
| Mar 2023 | - | $9.07 M(-0.8%) |
| Dec 2022 | $100.83 M | $9.14 M(+26.4%) |
| Sep 2022 | - | $7.23 M(-5.5%) |
| Jun 2022 | - | $7.65 M(+12.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $6.79 M(-2.3%) |
| Dec 2021 | $47.92 M(-36.9%) | $6.95 M(+1.1%) |
| Sep 2021 | - | $6.88 M(+9.9%) |
| Jun 2021 | - | $6.26 M(+12.5%) |
| Mar 2021 | - | $5.57 M(+13.3%) |
| Dec 2020 | $75.92 M(+650.2%) | $4.91 M(+30.1%) |
| Sep 2020 | - | $3.77 M(+10.6%) |
| Jun 2020 | - | $3.41 M(-34.7%) |
| Mar 2020 | - | $5.23 M(+7.9%) |
| Dec 2019 | $10.12 M(-59.4%) | $4.84 M |
| Dec 2018 | $24.93 M | - |
FAQ
- What is Lyra Therapeutics annual long term assets?
- What is the all time high annual non current assets for Lyra Therapeutics?
- What is Lyra Therapeutics annual non current assets year-on-year change?
- What is Lyra Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Lyra Therapeutics?
- What is Lyra Therapeutics quarterly non current assets year-on-year change?
What is Lyra Therapeutics annual long term assets?
The current annual non current assets of LYRA is $37.78 M
What is the all time high annual non current assets for Lyra Therapeutics?
Lyra Therapeutics all-time high annual long term assets is $37.78 M
What is Lyra Therapeutics annual non current assets year-on-year change?
Over the past year, LYRA annual long term assets has changed by +$28.64 M (+313.38%)
What is Lyra Therapeutics quarterly long term assets?
The current quarterly non current assets of LYRA is $24.31 M
What is the all time high quarterly non current assets for Lyra Therapeutics?
Lyra Therapeutics all-time high quarterly long term assets is $52.08 M
What is Lyra Therapeutics quarterly non current assets year-on-year change?
Over the past year, LYRA quarterly long term assets has changed by +$8.66 M (+55.30%)